Natera Shares Surge on Upbeat Forecast and Strategic Expansion

Natera’s latest quarterly earnings report has sent its stock on a volatile ride, with investors responding enthusiastically to dramatically raised full-year guidance despite recent pullbacks from peak valuations. The diagnostic company’s performance and future outlook are generating significant market attention.

For the third quarter of 2025, Natera delivered revenue of $592.18 million, representing a substantial 34.7% year-over-year increase and beating analyst projections by an impressive 15.77%. While the company reported a loss of $0.64 per share, missing earnings estimates, the market focus has shifted to Natera’s revised annual forecast.

The company significantly upgraded its full-year outlook with the following projections:
* Full-year 2025 revenue between $2.18 billion and $2.26 billion, representing a $160 million increase
Read more...